Virus-like particles (VLPs) are self-assembled structures derived from viral antigens that
mimic the native architecture of viruses but lack the viral genome. VLPs have emerged as a …

Biomolecules are increasingly attractive templates for the synthesis of functional
nanomaterials. Chief among them is the plant tobacco mosaic virus (TMV) due to its high …

Viral nanoparticles (VNPs) encompass a diverse array of naturally occurring nanomaterials
derived from plant viruses, bacteriophages, and mammalian viruses. The application and …

The fields of physical, chemical, and synthetic virology work in partnership to reprogram
viruses as controllable nanodevices. Physical virology provides the fundamental biophysical …

Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …

In the combat against pathogens, the immune systems were evolved with the immune
recognitions against the various danger signals, which responded vigorously upon the …

Virus-like particles (VLPs) have significant potential as artificial vaccines and drug delivery
systems. The ability to control their size has wide ranging utility but achieving such …

Viral protein cages, with their regular and programmable architectures, are excellent
platforms for the development of functional nanomaterials. The ability to transform a virus …

Virus-like particles (VLPs) consist of viral structural proteins that, when overexpressed,
spontaneously self-assemble into particles that are antigenically indistinguishable from …

Emerging infectious diseases are major threats to human health. Most severe viral disease
outbreaks occur in developing regions where health conditions are poor. With increased …